Wells Fargo’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
IC
YCM
EAM
VA
BFM
Wells Fargo's PASG Position: Q2 2026 in Review
Wells Fargo held its Passage Bio (PASG) position steady in Q2 2026 at 115 shares worth $561. The position accounts for ﹤0.01% of the portfolio, ranked #6509.
Wells Fargo first reported a position in PASG in Q2 2020 and has held it in 18 quarters since. The position peaked at $248K in Q4 2020. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.
- Wells Fargo held 115 shares of Passage Bio worth $561 as of Q2 2026.
- Wells Fargo left its Passage Bio share count unchanged in Q2 2026.
- Passage Bio made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6509 holding.
- Wells Fargo first reported a position in Passage Bio in Q2 2020 and has held it in 18 quarters since.
- Wells Fargo's Passage Bio position peaked at $248K in Q4 2020.
- 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.